The leukemia microenvironment associated with this signature showed enrichment of non-exhausted CD4<sup>+</sup> and CD8<sup>+</sup> T cytotoxic lymphocytes and expansion of CD8<sup>+</sup> T effector memory cells re-expressing CD45RA (TEMRA) in patients with a favorable prognosis. This evidence concerns the gene CD4 and leukemia.